The present invention provides compounds of Formula I
and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds act as diuretics and natriuretics and are valuable pharmaceutically active compounds for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension and conditions resulting from excessive salt and water retention.
本发明提供了I式化合物及其药学上可接受的盐,其是ROMK(Kir1.1)通道的
抑制剂。这些化合物作为利尿剂和
钠利尿剂,是治疗和预防包括高血压和由过度盐和
水潴留引起的疾病等医学状况的有价值的药学活性化合物。